ARID1A and cholangiocarcinoma: Molecularly, CCA is a highly heterogeneous disease, with genomic differences between intra and extrahepatic CCA [1,2,72,73], with IDH and FGFR pathway alterations predominantly found in intrahepatic cases, along with RAS and ARID1A [74].